Zacks Investment Research Lowers Molina Healthcare Inc (MOH) to Sell
Zacks Investment Research lowered shares of Molina Healthcare Inc (NYSE:MOH) from a hold rating to a sell rating in a research report report published on Tuesday.
According to Zacks, “Molina Healthcare suffers from rising medical care costs along with acute dependence on debt financing that has resulted in higher interest expenses draining the bottom line. Donald Trump’s decision of replacing the ObamaCare Act has resulted in an uncertain future of health care sector. The Zacks Consensus earnings estimate for both 2017 and 2018 has declined significantly over past 90 days. However, year to date, the shares gained 29% outperforming the Zacks classified Health Maintenance Organization that increased 21%. The company has been witnessing steady increase in premiums and service revenues over the past several quarters. Its several inorganic growth initiatives have paid off well. It will release the second quarter results On Aug 2, 2017. The Zacks Consensus Estimate is pegged at $0.86 for the second quarter reflecting a 29% year over year growth.”
A number of other equities research analysts have also recently issued reports on MOH. Jefferies Group LLC reissued a hold rating and issued a $61.00 price target on shares of Molina Healthcare in a research note on Thursday, June 8th. Stifel Nicolaus cut shares of Molina Healthcare from a hold rating to a sell rating and lifted their price target for the company from $47.00 to $60.00 in a research note on Wednesday, May 31st. Wolfe Research reissued a market perform rating and issued a $69.00 price target on shares of Molina Healthcare in a research note on Monday, May 15th. ValuEngine raised shares of Molina Healthcare from a hold rating to a buy rating in a research note on Friday, June 2nd. Finally, Morgan Stanley started coverage on shares of Molina Healthcare in a research note on Tuesday, June 6th. They issued an underweight rating and a $65.00 price target on the stock. Five equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the stock. Molina Healthcare currently has a consensus rating of Hold and an average price target of $60.37.
Shares of Molina Healthcare (MOH) traded up 0.09% during trading on Tuesday, hitting $70.26. 602,692 shares of the company were exchanged. The firm has a market capitalization of $4.01 billion, a PE ratio of 37.75 and a beta of 0.91. The firm’s 50-day moving average price is $68.04 and its 200 day moving average price is $56.55. Molina Healthcare has a 12 month low of $42.56 and a 12 month high of $72.15.
TRADEMARK VIOLATION NOTICE: This story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/07/17/zacks-investment-research-lowers-molina-healthcare-inc-moh-to-sell.html.
In other Molina Healthcare news, Director John C. Molina sold 15,393 shares of Molina Healthcare stock in a transaction on Wednesday, May 3rd. The shares were sold at an average price of $65.00, for a total transaction of $1,000,545.00. Following the sale, the director now owns 693,599 shares of the company’s stock, valued at approximately $45,083,935. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Daniel Cooperman sold 7,542 shares of Molina Healthcare stock in a transaction on Friday, May 5th. The stock was sold at an average price of $65.74, for a total transaction of $495,811.08. Following the sale, the director now directly owns 11,992 shares in the company, valued at approximately $788,354.08. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 174,042 shares of company stock worth $11,791,712. 6.20% of the stock is currently owned by corporate insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. raised its position in Molina Healthcare by 5.0% in the first quarter. Vanguard Group Inc. now owns 3,553,229 shares of the company’s stock valued at $162,028,000 after buying an additional 170,294 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Molina Healthcare by 12.8% in the first quarter. Dimensional Fund Advisors LP now owns 2,488,977 shares of the company’s stock valued at $113,498,000 after buying an additional 282,144 shares in the last quarter. Alliancebernstein L.P. raised its position in Molina Healthcare by 1.7% in the first quarter. Alliancebernstein L.P. now owns 1,908,612 shares of the company’s stock valued at $87,033,000 after buying an additional 31,548 shares in the last quarter. Victory Capital Management Inc. raised its position in Molina Healthcare by 20.0% in the first quarter. Victory Capital Management Inc. now owns 1,583,018 shares of the company’s stock valued at $72,186,000 after buying an additional 263,892 shares in the last quarter. Finally, Tiedemann Wealth Management LLC raised its position in Molina Healthcare by 3.1% in the first quarter. Tiedemann Wealth Management LLC now owns 1,408,414 shares of the company’s stock valued at $64,224,000 after buying an additional 42,301 shares in the last quarter. Institutional investors and hedge funds own 92.96% of the company’s stock.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related stocks with our FREE daily email newsletter.